Patents by Inventor Magalie Dosset

Magalie Dosset has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Universal cancer peptides derived from telomerase
    Patent number: 10695409
    Abstract: The invention relates to a peptide of 15 to 20 amino acids deriving from TERT protein, which peptide is capable of (i) binding to HLA class II and (ii) stimulating a CD4 Th response. These universal cancer peptides are especially useful in anti-tumor immunotherapy and immunomonitoring.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: June 30, 2020
    Assignees: INVECTYS, UNIVERSITE DE FRANCHE-COMTE, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BESANCON
    Inventors: Pierre Langlade Demoyen, Olivier Adotevi, Magalie Dosset
  • UNIVERSAL CANCER PEPTIDES DERIVED FROM TELOMERASE
    Publication number: 20170360914
    Abstract: The invention relates to a peptide of 15 to 20 amino acids deriving from TERT protein, which peptide is capable of (i) binding to HLA class II and (ii) stimulating a CD4 Th response. These universal cancer peptides are especially useful in anti-tumor immunotherapy and immunomonitoring.
    Type: Application
    Filed: May 31, 2017
    Publication date: December 21, 2017
    Applicants: INVECTYS, Universite De Franche-Comte, Centre Hospitalier Regional Universitaire De Besancon
    Inventors: Pierre Langlade Demoyen, Olivier Adotevi, Magalie Dosset
  • Universal cancer peptides derived from telomerase
    Patent number: 9669080
    Abstract: The invention relates to a peptide of 15 to 20 amino acids deriving from TERT protein, which peptide is capable of (i) binding to HLA class II and (ii) stimulating a CD4 Th response. These universal cancer peptides are especially useful in anti-tumor immunotherapy and immunomonitoring.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: June 6, 2017
    Assignees: INVECTYS, Universite De Franche-Comte, Centre Hospitalier Regional Universitaire De Besancon
    Inventors: Pierre Langlade Demoyen, Olivier Adotevi, Magalie Dosset
  • UNIVERSAL CANCER PEPTIDES DERIVED FROM TELOMERASE
    Publication number: 20150283219
    Abstract: The invention relates to a peptide of 15 to 20 amino acids deriving from TERT protein, which peptide is capable of (i) binding to HLA class II and (ii) stimulating a CD4 Th response. These universal cancer peptides are especially useful in anti-tumor immunotherapy and immunomonitoring.
    Type: Application
    Filed: March 7, 2013
    Publication date: October 8, 2015
    Applicants: INVECTYS, Universite De Franche-Comte, Centre Hospitalier Regional Universitaire De Besancon
    Inventors: Pierre Langlade Demoyen, Olivier Adotevi, Magalie Dosset